You are now leaving the Lilly Medical website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Orforglipron-Diabetes
Foundayo ™ (orforglipron) tablet
0.8 mg / 2.5 mg / 5.5 mg / 9 mg / 14.5 mg / 17.2 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling.
Where is Foundayo™ (orforglipron) absorbed?
Orforglipron is for daily oral use. The specific site of absorption within the gastrointestinal tract has not been studied by Eli Lilly and Company.
See important safety information, including boxed warning, in the attached prescribing information.
Where in the Gastrointestinal Tract Is Orforglipron Absorbed?
Orforglipron is for daily oral use. Take orforglipron orally once daily, with or without food.1
There are no clinical data available to determine the specific site of absorption of orforglipron within the gastrointestinal tract, as this has not been studied by Eli Lilly and Company.
Most orally administered drugs are absorbed in the small intestine, particularly the proximal regions (duodenum and jejunum), due to favorable permeability, surface area, and physiological conditions.2 Eli Lilly and Company has not conducted studies to specifically evaluate the site of absorption of orally administered orforglipron.
Enclosed Prescribing Information
FOUNDAYO™ (orforglipron) tablets, for oral use, Lilly
References
The published reference below is available by contacting 1-800-LillyRx (1-800-545-5979).
- Foundayo [package insert]. Indianapolis, IN: Eli Lilly and Company; 2026.
- Murakami T. Absorption sites of orally administered drugs in the small intestine. Expert Opin Drug Discov. 2017;12(12):1219-1232. https://doi.org/10.1080/17460441.2017.1378176
Date of Last Review: May 08, 2026